In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 | NEJM

Retrieved on: 2022-11-16 22:03:33

Tags for this article:

Internet privacy

Hacking

World Wide Web

Computer access control

Click the tags to see associated articles and topics

In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 | NEJM. View article details on HISWAI: https://www.nejm.org/doi/full/10.1056/NEJMc2211845

Excerpt

Our data suggest that remdesivir, molnupiravir, and nirmatrelvir and the monoclonal antibodies bebtelovimab and imdevimab retain effectiveness against ...

Article found on: www.nejm.org

View Original Article